| Cover | Jan. 07, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Jan. 07, 2024 |
| Entity File Number | 001-40344 |
| Entity Registrant Name | Akoya Biosciences, Inc. |
| Entity Central Index Key | 0001711933 |
| Entity Tax Identification Number | 47-5586242 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 100 Campus Drive |
| Entity Address, Address Line Two | 6th Floor |
| Entity Address, City or Town | Marlborough |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 01752 |
| City Area Code | 855 |
| Local Phone Number | 896-8401 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common stock, par value $0.00001 per share |
| Trading Symbol | AKYA |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
